After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Globus Medical Inc is $11.86B. A total of 2.95 million shares were traded on the day, compared to an average of 935.33K shares.
In the most recent transaction, Pfeil Keith W bought 14,167 shares of GMED for 88.29 per share on Jan 10 ’25. In a previous transaction on Dec 02 ’24, Huller Kelly sold 2,500 shares at 87.00 per share. GMED shares that SVP, GC, Corporate Secretary owns now total 0.
Among the insiders who bought shares, Huller Kelly acquired of 2,500 shares on Dec 02 ’24 at a per-share price of $86.95. In another insider transaction, Davidar David D sold 13,254 shares at $85.00 per share on Nov 21 ’24. Company shares held by the Director now total 172,713.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, GMED has a high of $87.22 and a low of $49.33.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. GMED’s latest balance sheet shows that the firm has $443.45M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $29.94, while its Total Shareholder’s Equity was $1.74B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GMED is Buy with a score of 4.27.
